| Basics |
| Company: |
Mineralys Therapeutics, Inc. |
| IPO Date: |
February 10, 2023 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$476.43M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.34 | 2.79%
|
| Avg Daily Range (30 D): |
$0.32 | 3.06%
|
| Avg Daily Range (90 D): |
$0.33 | 2.76%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.16M |
| Avg Daily Volume (30 D): |
.26M |
| Avg Daily Volume (90 D): |
.19M |
| Trade Size |
| Avg Trade Size (Sh.): |
71 |
| Avg Trade Size (Sh.) (30 D): |
66 |
| Avg Trade Size (Sh.) (90 D): |
59 |
| Institutional Trades |
| Total Inst.Trades: |
122 |
| Avg Inst. Trade: |
$1.63M |
| Avg Inst. Trade (30 D): |
$.6M |
| Avg Inst. Trade (90 D): |
$.84M |
| Avg Inst. Trade Volume: |
.13M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.46M |
| Avg Closing Trade (30 D): |
$.7M |
| Avg Closing Trade (90 D): |
$.89M |
| Avg Closing Volume: |
259.8K |
|
|
|
|
| News |
Sep 25, 2024 @ 12:00 PM
Mineralys Therapeutics Completes Target Enrollment...
Source: N/A
|
Sep 16, 2024 @ 8:00 PM
MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossm...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Jun 14, 2024 @ 12:00 PM
Mineralys Therapeutics Appoints Biopharmaceutical ...
Source: Mineralys Therapeutics, Inc.
|
Mar 13, 2024 @ 8:05 PM
Mineralys Therapeutics to Announce Fourth Quarter ...
Source: Mineralys Therapeutics, Inc.
|
Feb 8, 2024 @ 6:07 PM
Why Compass Minerals International Shares Are Trad...
Source: Avi Kapoor
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-3.31
|
$-1.13
|
$-.83
|
|
Diluted EPS
|
$-3.31
|
$-1.13
|
$-.83
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -153.25M
|
$ -56.34M
|
$ -41.01M
|
|
Operating Income / Loss
|
$ -168.35M
|
$ -60.11M
|
$ -45.17M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 10.97M
|
$ 29.42M
|
$ -22.56M
|
|
PE Ratio
|
|
|
|
|
